Mar 23, 2021 | Alternative Reimbursement Strategies, Cost Savings, Direct-to-Employer Contracting, Reference-Based Pricing, Savings
In 2020, MedBen alternative reimbursement strategies outperformed traditional PPO plans by 23.5%. Strategies like reference-based pricing (RBP) and direct-to-employer (DTE) contracting offer better pricing to employers and members. There are many RBP strategies...Feb 23, 2021 | Announcements, Compliance, Cost Savings, Direct-to-Employer Contracting, MedBen Analytics, MedBen Rx, MedBen University, Reference-Based Pricing, Regulatory, Rx Costs, Savings, Webinars
We are excited to announce the 20th Season of MedBen University (MBU). Our 2021 season starts with virtual roundtables and focus on topics including: New and emerging strategies for Rx benefits, with case studies Growing popularity of direct-to-employer contracting,...Feb 8, 2021 | Cost Savings, Emergency Room (ER), Primary Care, Savings, Urgent Care, Wellness
Many people use the emergency room as a place to receive after-hours care for minor illnesses or injuries without realizing they have another option for far less cost. For MedBen clients in 2020, 23% of ER visits were potentially avoidable. The table below lists...Feb 4, 2021 | Cost Savings, Flexible spending accounts (FSAs), Online Services, Savings
Not only is the FSA Store an easy way to shop for FSA-eligible products with your MedBen Debit Card, it’s a convenient way to check what is eligible! The comprehensive FSA Eligibility List contains thousands of items FSA users can purchase with tax-free funds....Jan 26, 2021 | Announcements, Claims Management, Cost Savings, Forensic claims analysis, Savings
In 2020, MedBen clients saved on average an additional 53.4% on targeted claims through our forensic claims review. These savings are in addition to any PPO discounts. Forensic claims review brings together skilled claims examiners, an advanced surveillance system,...Jan 10, 2021 | Brand Name Drugs, Cost Savings, Generic Drugs, Prescription, Rx Costs, Savings, Specialty Drugs
GoodRx has compiled a list of drugs that saw manufacturer price increases in January 2021. In total, 589 drugs – all but seven of them brand-name medications – increased in price, by an average of 4.2%. Among the better known brand-name drugs on the list are Humira...